(Q37768057)

22 August 2017

1 reference

title

Aberrant methylation in non-small cell lung cancer (English)

1 reference

22 August 2017

1 reference

Makoto Suzuki

1

1 reference

PubMed ID

20582509

22 August 2017

Ichiro Yoshino

series ordinal

2

1 reference

22 August 2017

26 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

40

1 reference

22 August 2017

602-607

1 reference

22 August 2017

7

1 reference

Worms gang up on bacteria

22 August 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00595-009-4094-6

In vitro induction of myeloid leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteins

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00595-009-4094-6

The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.

21 January 2018

1 reference

12 December 2020

Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.

1 reference

12 December 2020

DNA methylation markers and early recurrence in stage I lung cancer

1 reference

12 December 2020

The methylome: approaches for global DNA methylation profiling

1 reference

12 December 2020

Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer

1 reference

12 December 2020

Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.

1 reference

12 December 2020

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

12 December 2020

Aberrant methylation of Reprimo in lung cancer

1 reference

12 December 2020

Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers

1 reference

12 December 2020

Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.

1 reference

12 December 2020

Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer

1 reference

12 December 2020

Aberrant methylation of FBN2 in human non-small cell lung cancer

1 reference

12 December 2020

SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway

1 reference

12 December 2020

14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group

1 reference

12 December 2020

Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer

1 reference

12 December 2020

Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells

1 reference

12 December 2020

Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma

1 reference

12 December 2020

Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.

1 reference

12 December 2020

Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis

1 reference

12 December 2020

MicroRNA biogenesis: coordinated cropping and dicing

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay

1 reference

12 December 2020

Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine

1 reference

12 December 2020

Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer

1 reference

12 December 2020

Sensitive Detection of DNA Methylation

1 reference

12 December 2020

Epigenetic changes in prostate cancer: implication for diagnosis and treatment

1 reference

12 December 2020

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells

1 reference

12 December 2020

Potential of 5-aza-2'-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer

1 reference

12 December 2020

Prognostic value of apoptosis-associated speck-like protein containing a CARD gene promoter methylation in resectable non-small-cell lung cancer.

1 reference

12 December 2020

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

1 reference

12 December 2020

p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients.

1 reference

12 December 2020

Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells

1 reference

12 December 2020

Predicting lung cancer by detecting aberrant promoter methylation in sputum

1 reference

12 December 2020

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

1 reference

12 December 2020

Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program

1 reference

12 December 2020

A gene hypermethylation profile of human cancer

1 reference

12 December 2020

Oncomirs - microRNAs with a role in cancer

1 reference

12 December 2020

Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer

1 reference

12 December 2020

Using expression profiling data to identify human microRNA targets

1 reference

12 December 2020

Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes

1 reference

12 December 2020

Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3

1 reference

12 December 2020

Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.

1 reference

12 December 2020

p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.

1 reference

12 December 2020

Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome

1 reference

12 December 2020

Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer

1 reference

12 December 2020

DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells

1 reference

12 December 2020

Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.

1 reference

12 December 2020

Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools

1 reference

12 December 2020

Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.

1 reference

12 December 2020

Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis

1 reference

12 December 2020

5-aza-2'-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis

1 reference

12 December 2020

DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma

1 reference

12 December 2020

Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer

1 reference

12 December 2020

Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer

1 reference

12 December 2020

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

1 reference

12 December 2020

Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers

1 reference

12 December 2020

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.

1 reference

12 December 2020

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

1 reference

12 December 2020

Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer.

1 reference

12 December 2020

Molecular diagnostic applications of DNA methylation technology

1 reference

12 December 2020

RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells

1 reference

12 December 2020

Epigenetic down-regulation of death-associated protein kinase in lung cancers.

1 reference

12 December 2020

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

1 reference

12 December 2020

Cancer statistics, 2007

1 reference

12 December 2020

Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura

1 reference

12 December 2020

The fundamental role of epigenetic events in cancer

1 reference

12 December 2020

10.1007/S00595-009-4094-6

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20582509